SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Cambridge Antibody Technology Group -- Ignore unavailable to you. Want to Upgrade?


To: keokalani'nui who wrote (513)11/22/2004 2:16:09 PM
From: nigel bates  Read Replies (1) | Respond to of 625
 
I'll email CAT IR tomorrow.

CAMBRIDGE, England, Nov. 22 /PRNewswire-FirstCall/ -- Cambridge Antibody Technology (LSE: CAT - News; Nasdaq: CATG - News) today announces that, during the course of today's hearing in the High Court in London, following an application from a third party, the judge made an order that certain court documents including opening submissions could be made available to third parties.

Copies of such documents will be available upon request from CAT's corporate communications team on +44 (0) 1223 471 471 or by emailing public.relations@cambridgeantibody.com not before noon GMT on 23 November 2004.